Free Trial

Gain Therapeutics (GANX) Institutional Ownership

$1.21
-0.01 (-0.82%)
(As of 07/19/2024 ET)

Institutional Ownership Changes (13F Filings) for Gain Therapeutics (NASDAQ:GANX)

Current
Institutional Ownership
Percentage
11.97%
Number of
Institutional Buyers
(last 12 months)
1
Total
Institutional Inflows
(last 12 months)
$60.03K
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$32.69K
Get GANX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Gain Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

GANX Institutional Buying and Selling by Quarter

Gain Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
1/16/2024 Raymond James & Associates23,788$78K0.0%-29.6%0.184%
7/25/2023 Raymond James & Associates33,400$150K0.0%+67.0%0.271%
5/8/2023CM Management LLC90,000$434K0.5%-18.2%0.740%
5/2/2023Wealth Alliance Advisory Group LLC12,502$60K0.0%-33.3%0.105%
4/14/2023 Raymond James & Associates20,000$96K0.0%-16.7%0.168%
2/9/2023CM Management LLC110,000$344K0.4%-12.0%0.926%
1/17/2023Wealth Alliance Advisory Group LLC18,751$59K0.0%-25.0%0.158%
11/17/2022Telemetry Investments L.L.C.150,000$489K0.6%-6.3%1.263%
10/25/2022 Raymond James & Associates24,000$78K0.0%N/A0.202%
10/12/2022Wealth Alliance Advisory Group LLC25,000$82K0.0%N/A0.210%
5/9/2022CM Management LLC125,000$511K0.4%+38.9%1.052%
2/3/2022Advisor Group Holdings Inc.10,050$54K0.0%N/A0.085%
2/2/2022CM Management LLC90,000$489K0.4%+39.9%0.758%
11/16/2021Telemetry Investments L.L.C.96,232$716K1.0%+217.7%0.810%
11/15/2021Veritable L.P.25,064$187K0.0%N/A0.211%
11/9/2021Indie Asset Partners LLC29,652$221K0.2%N/A0.250%
11/8/2021CM Management LLC64,327$479K0.4%+543.3%0.542%
8/17/2021Bridgeway Capital Management LLC50,000$501K0.0%N/A0.421%
8/16/2021Telemetry Investments L.L.C.30,293$303K0.4%N/A0.255%
8/11/2021Banque Cantonale Vaudoise3,000$30K0.0%N/A0.025%
8/10/2021CM Management LLC10,000$100K0.1%N/A0.084%
5/27/2021Davidson Kempner Capital Management LP15,000$222K0.0%N/A0.126%
5/19/2021Worth Venture Partners LLC15,532$232K0.1%N/A0.131%
5/18/2021Millennium Management LLC14,367$214K0.0%N/A0.121%
5/18/2021Greenlight Capital Inc.546,560$8.16M0.6%N/A4.602%
5/18/2021Davidson Kempner Capital Management LP15,000$222K0.0%N/A0.126%
5/18/2021Jane Street Group LLC22,754$339K0.0%N/A0.192%
(Data available from 1/1/2016 forward)

GANX Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of GANX shares?

During the previous two years, the following institutional investors and hedge funds held shares of Gain Therapeutics shares: Telemetry Investments L.L.C. ($489K), CM Management LLC ($434K), and Raymond James & Associates ($78K), Wealth Alliance Advisory Group LLC ($60K).Learn more on GANX's institutional investors.

What percentage of Gain Therapeutics stock is owned by institutional investors?

11.97% of Gain Therapeutics stock is owned by institutional investors. Learn more on GANX's institutional investor holdings.

Which institutional investors have been buying Gain Therapeutics stock?

The following institutional investors have purchased Gain Therapeutics stock in the last 24 months: Raymond James & Associates ($37.40K), and Wealth Alliance Advisory Group LLC ($25K).

How much institutional buying is happening at Gain Therapeutics?

Institutional investors have bought a total of 62,400 shares in the last 24 months. This purchase volume represents approximately $219.77K in transactions.

Which Gain Therapeutics major shareholders have been selling company stock?

The following institutional investors have sold Gain Therapeutics stock in the last 24 months: CM Management LLC ($35K), Raymond James & Associates ($14.01K), Wealth Alliance Advisory Group LLC ($12.50K), and Telemetry Investments L.L.C. ($10K).

How much institutional selling is happening at Gain Therapeutics?

Institutional investors have sold a total of 71,510 shares in the last 24 months. This volume of shares sold represents approximately $277.60K in transactions.


This page (NASDAQ:GANX) was last updated on 7/21/2024 by MarketBeat.com Staff

From Our Partners